B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

COPI-mediated anterograde transport

REACTOME PATHWAY
Reactome: R-HSA-680787819 genes17 compounds

The COPI-mediated anterograde transport pathway (Reactome ID: R-HSA-6807878) involves 19 genes and is affected by 17 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

FOLR1INSTUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBA8TUBAL3TUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TUBB8B

Compounds Affecting COPI-mediated anterograde transport

#CompoundTargets HitStudies
1Colchicine300
2Nocodazole Nocodazole is215
3Vincristine299
4Noscapine300
5Podophyllotoxin14
6Demecolcine246
7Maytansine300
8vinblastine sulfate81
9Vorinostat299
10Digitoxin300
11Digoxin299
12Flutamide298
13m0842
14Thiabendazole 2-Substituted benzimidazole first introduced in 1962. It is active against299
15Pemetrexed299
16Methotrexate289
17Folic Acid296

About the COPI-mediated anterograde transport Pathway

The COPI-mediated anterograde transport pathway is catalogued in Reactome (ID: R-HSA-6807878) and involves 19 genes. In the BiohacksAI corpus, 17 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include FOLR1, INS, TUBA1A, TUBA1B, TUBA1C.